Body Protection Compound 157, PL 14736. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
The studies behind this compound did not test timing or food state as variables, so we are not going to invent a rule. Pick a time you can keep to consistently.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Weeks 1–2 start here |
500 mcg | daily | 0.1 mL | 10 u | 14 | 7 mg |
| Weeks 3–4 | 1 mg | daily | 0.2 mL | 20 u | 14 | 14 mg |
| Week 5 onward most stop here most stay here |
2 mg | daily | 0.4 mL | 40 u | 14 | 28 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Start | 500 mcg | daily | 0.1 mL | 10 u | 20 doses |
| Mid | 1 mg | daily | 0.2 mL | 20 u | 10 doses |
| Upper | 2 mg | daily | 0.4 mL | 40 u | 5 doses |
A mitochondrial-derived peptide, from the same family as MOTS-c. Preclinical work examines cytoprotection, metabolic signalling and neuronal survival models. Most published research uses potent analogues such as HNG rather than native humanin, and dosing figures do not transfer cleanly between the two. No human dosing trials.
Buy HumaninPaid affiliate links.
Adding 2 mL of bacteriostatic water to a 10 mg vial gives 5 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.
Published and reported figures for Humanin on this protocol run from 500 mcg to 2 mg daily, stepping up over four weeks. This site lists each figure with the source it came from rather than giving a single recommended number.
At 5 mg/mL, a 500 mcg dose is 10 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 20 doses.
Humanin is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.
Compounds in the same class, or browse the full catalogue.
The C-terminal tripeptide of α-melanocyte-stimulating hormone, studied for anti-inflammatory activity in colitis and dermatitis mo…
A synthetic fragment of thymosin beta-4, the actin-sequestering protein. Full-length Tβ4 reached human trials for dry eye and card…
Every compound compared in one table: dose range, how often, half-life and evidence tier.
Need this on one page to print, screenshot or send?
Make a dose card →